Cargando…
Editorial: Novel targets for ovarian cancer stem cells
Autores principales: | Wang, Yinu, Sima, Livia E., Jia, Dongyu, Zhao, Guangyuan, Zhang, Yaqi, Xie, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646609/ https://www.ncbi.nlm.nih.gov/pubmed/38023161 http://dx.doi.org/10.3389/fonc.2023.1325066 |
Ejemplares similares
-
FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway
por: Zhang, Yaqi, et al.
Publicado: (2022) -
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
por: Sima, Livia Elena, et al.
Publicado: (2021) -
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020) -
Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023) -
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2019)